A Randomized, Double-blind, Parallel Group, Proof of Concept Study of YM178 in Comparison With Placebo and Tolterodine in Patients With Symptomatic Overactive Bladder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The study is intended to test efficacy, safety and tolerability of two doses of YM178 against placebo and tolterodine to treat patients with symptoms of over active bladder.
Epistemonikos ID: cdd5f9d09ff0aa5094fd1572bbb6352b228aa4fb
First added on: May 11, 2024